Mark Lebwohl - Böcker

Using a convenient A-to-Z organization, Treatment of Skin Disease, 7th Edition, covers more than 260 of the dermatologic conditions you’re most likely to encounter. This award-winning, up-to-date text puts every possible therapeutic option at your disposal-including management strategies, first- to third-line therapies, and off-label uses-for a truly complete guide to the vast array of dermatologic treatment options. Summaries of each treatment strategy are accompanied by detailed discussions of treatment choices, with clear evidence levels ranging from double-blind randomised controlled trials to anecdotal reports.

**Selected for Doody’s Core Titles� 2024 in Dermatology**Covering nearly 260 of the most common dermatologic conditions from A to Z, Treatment of Skin Disease, 6th Edition, by Drs. Mark G. Lebwohl, Warren R. Heymann, Ian Coulson, and Dedee Murrell, is your go-to resource for authoritative, evidence-based treatment strategies in your daily practice. This award-winning text provides guidance on the fast-moving dermatological therapy options for virtually any skin disease you’re likely to encounter, including third-line and unusual therapies when initial options have not been successful. Summaries of each treatment strategy are accompanied by detailed discussions of treatment choices, with ratings on a consistent scale ranging from clinical studies to anecdotal reports.

Using a practical and problem-focused approach, this updated, full-color Third Edition of Mild-to-Moderate Psoriasis equips dermatologists, internists, family practitioners, and residents with a state-of-the-art guide to the clinical management of mild-to-moderate psoriasis. Written by an international team of key opinion leaders, this resource explores new developments in treatments for the condition and provides clinicians with up-to-date strategies for optimal patient management.

The understanding of the mechanisms behind the disease and the available treatment options have continued to develop rapidly in recent times, with this vital resource covering the latest in these management options, including targeted T-cell therapy, the use of immunomodulators, systemic therapies, and ultraviolet and laser therapy.